Eli Lilly and Company (LLY)
NYSE · Healthcare
Eli Lilly and Company Revenue 2020–2025
Eli Lilly and Company annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Eli Lilly and Company revenue for the quarter ending March 31, 2026 was 19.8 B, a 55.55% increase year-over-year.
- Eli Lilly and Company revenue for the twelve months ending March 31, 2026 was 72.2 B.
- Eli Lilly and Company annual revenue for 2025 was 65.2 B, a 44.70% increase from 2024.
- Eli Lilly and Company annual revenue for 2024 was 45.0 B, a 32.00% increase from 2023.
- Eli Lilly and Company annual revenue for 2023 was 34.1 B, a 19.56% increase from 2022.
- Eli Lilly and Company annual revenue for 2022 was 28.5 B.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Eli Lilly and Company Earnings — FAQ
Eli Lilly and Company (LLY) earnings over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LLY's earnings history?
The chart and table above show Eli Lilly and Company's earnings by year and by quarter, including the growth rate.